Ikarian Capital, LLC Poseida Therapeutics, Inc. Transaction History

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$7.09 - $10.71 $608,584 - $919,314
-85,837 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$8.51 - $11.91 $1.4 Million - $1.97 Million
-165,000 Reduced 65.78%
85,837 $820,000
Q4 2020

Feb 12, 2021
BUY
$8.29 - $11.7 $189,318 - $267,192
22,837 Added 10.02%
250,837 $2.75 Million
Q3 2020

Nov 16, 2020
BUY
$8.09 - $16.25 $1.84 Million - $3.71 Million
228,000 New
228,000 $2.02 Million

Others Institutions Holding PSTX

# of Institutions
98
Shares Held
38.5M
Call Options Held
377K
Put Options Held
22.2K
View Full List

About Poseida Therapeutics, Inc.

PSTX Quotes by TradingView
  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $810M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email